ESALF (Eisai Co) 5-Year Yield-on-Cost %: 4.07 (As of Jul. 05, 2026) — 75% Above Median


ESALF Eisai Co Ltd ESALF
69 GF Score
Price $25.00
GF Value $33.57
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eisai Co 5-Year Yield-on-Cost %?

Eisai Co ESALF 69 5-Year Yield-on-Cost % is 4.07 as of Jul. 05, 2026, which is 75% above its 10-year median of 2.32. GuruFocus rates ESALF with a GF Score™ of 69/100 and a GF Value™ of $33.57 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 517 Drug Manufacturers companies, Eisai Co ranks better than 64.6% on this metric.

Eisai Co's yield on cost for the quarter that ended in Mar. 2026 was 4.07.


The historical rank and industry rank for Eisai Co's 5-Year Yield-on-Cost % or its related term are showing as below:

ESALF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.33   Med: 2.32   Max: 4.51
Current: 4.07


During the past 13 years, Eisai Co's highest Yield on Cost was 4.51. The lowest was 1.33. And the median was 2.32.


ESALF's 5-Year Yield-on-Cost % is ranked better than
64.6% of 517 companies
in the Drug Manufacturers industry
Industry Median: 2.26 vs ESALF: 4.07

Eisai Co  (OTCPK:ESALF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Eisai Co 5-Year Yield-on-Cost % Related Terms


ESALF vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eisai Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eisai Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Eisai Co's 5-Year Yield-on-Cost % falls into.


ESALF
69GF Score
Eisai Co Ltd ESALF
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eisai Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Eisai Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 4.07 mean?
Eisai Co (ESALF) has a 5-Year Yield-on-Cost % of 4.07 as of Jul. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Eisai Co and its competitors. This is 75% above median its historical median of 2.32. Over the past decade, Eisai Co's 5-Year Yield-on-Cost % has ranged from 1.33 to 4.51. According to the industry distribution chart, Eisai Co ranks #183 out of 517 companies in the Drug Manufacturers industry, placing it in the top 35.4%.
Is Eisai Co's 5-Year Yield-on-Cost % too high?
Eisai Co's current 5-Year Yield-on-Cost % of 4.07 is 75% above median its 10-year median of 2.32. Over the past 10 years, this metric has ranged from a low of 1.33 to a high of 4.51. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.26. Eisai Co's value of 4.07 is 80.1% above this industry median. Based on the distribution chart, Eisai Co ranks #183 out of 517 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Eisai Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eisai Co's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Eisai Co ranks #183 out of 517 companies for 5-Year Yield-on-Cost %. This puts Eisai Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.26. Eisai Co's value of 4.07 is 80.1% above this benchmark. Historically, Eisai Co's own 5-Year Yield-on-Cost % has ranged from 1.33 to 4.51 over the past decade. While the company's 10-year median is 2.32 vs. the industry median of 2.26, Eisai Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.26, based on 517 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eisai Co's current 5-Year Yield-on-Cost % of 4.07 is 80.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Eisai Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eisai Co's current 5-Year Yield-on-Cost % is 4.07, which is 75% above median its own 10-year median of 2.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eisai Co stock overvalued right now?
Based on GuruFocus' analysis, Eisai Co (ESALF) is currently considered Modestly Undervalued. The stock's GF Value™ is $33.57, compared to a current price of $25.00 — trading 25.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 4.07, which is 75% above median its 10-year median of 2.32 and 80.1% above the Drug Manufacturers industry median of 2.26. Eisai Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Eisai Co (ESALF), the current 5-Year Yield-on-Cost % is 4.07 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eisai Co (ESALF) Overvalued in 2026?

Based on GuruFocus' analysis, Eisai Co stock appears to be undervalued. The current stock price of $25.00 is trading 25.5% below its estimated GF Value™ of $33.57. GuruFocus considers Eisai Co to be Modestly Undervalued.

Key valuation signals for ESALF:

  • 5-Year Yield-on-Cost %: 4.07 (75% above median its 10-year median of 2.32)
  • GF Value™: $33.57 vs. price of $25.00 (25.5% below fair value)
  • GF Score™: 69/100 with 6 warning signs
  • Industry Position: 80.1% above the Drug Manufacturers median (#183 of 517)

No single metric tells the full story. See the ESALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eisai Co Business Description

Address 4-6-10 Koishikawa, Bunkyo-ku, Tokyo, JPN, 112-8088
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
69GF Score

Get the complete analysis for ESALF

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.00
Price
$33.57
GF Value